Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Single-center Comparative Study of Variation in Acetabular Anteversion According to Pelvic Tilt in Patients With Femoro-acetabular Impingement and Healthy Volunteers.

NCT05678894 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2023-09-28
Last updated
2025-12-03

Condition(s) studied

Femoro-acetabular Impingement

Investigational drug(s) / intervention(s)

Scanner and EOS imaging

Scanner and EOS imaging: Cross-sectional imaging and 3D reconstruction to measure and compare acetabular anteversion in 4 functional pelvic positions.

Study summary

The main objective is to show that the upper acetabular anteversions calculated in standing, sitting, sitting hip in maximum flexion and supine positions are lower in patients with symptomatic DWI compared to healthy volunteers.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion criteria for symptomatic patients: * Patient at least 18 years of age but \< 50 years of age * Patient with a confirmed diagnosis of DWI for whom arthroscopic impingement surgery is proposed * Patient who has given and signed free and informed consent * A patient who is a member of a social security plan or a beneficiary of such a plan Healthy volunteer inclusion criteria: * Person at least 18 years of age but \< 50 years of age * Person with no existing DWI diagnosis * Person who has given and signed free and informed consent * Person affiliated with a social security plan or beneficiary of such a plan Exclusion Criteria: * Patient who has already undergone surgery on the same hip * Patient with previous spine surgery * Patient already included in the study for the opposite hip * Pregnant or breastfeeding patient * Patient who did not give consent * Patient for whom it is impossible to give informed information * Mentally impaired or any other reason that may interfere with understanding * Patient under court protection, guardianship or curatorship * Patient in an exclusion period as determined by another study

Primary outcome measure(s)

  • Anteversions comparison — Day 0
    Comparison of anteversions of the superior plane of the acetabulum obtained from 3D CT reconstruction of the pelvis positioned standing, seated, seated hip in maximum flexion, and supine after matching by low-dose EOS X-ray images, between patients with symptomatic DWI and healthy volunteers.

Trial sites (1)

FacilityCityRegionStatus
Clinique de la Sauvegarde Lyon France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05678894 on ClinicalTrials.gov ↗ ← All trials in France